Hyperglycemia and the vascular effects of cerebral ischemia

Stroke

Volumn 28, Issue 1, 1997, Pages 149-154

  Kawai, Nobuyuki ^a   Keep, Richard F ^a   Betz, A Lorris ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cerebral blood flow; cerebral blood volume; cerebral hemorrhage; cerebral ischemia; hyperglycemia

Indexed keywords

KETAMINE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; HYPERGLYCEMIA; INSULIN RELEASE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PLASMA VOLUME; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE INJURY; VASCULARIZATION;

EID: 0031034091     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.1.149     Document Type: Article

References (27)

1. Lin T-N, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117-121.
2. Menzies SA, Betz AL, Hoff JT. Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J Neurosurg. 1993;78:257-266.
3. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology. 1991;41:899-905.
4. Hsu WH, Hummel SK. Xylazine-induced hyperglycemia in cattle: a possible involvement of alpha 2-adrenergic receptors regulating insulin release. Endocrinology. 1981;109:825-829.
5. de Courten-Myers G, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke. 1988; 19:623-630.
6. Pardo R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab. 1988;8:186-192.
7. Nedergaard M. Transient focal ischemia in hyperglycemic rats is associated with increased cerebral infarction. Brain Res. 1987;408:79-85.
8. Chopp M, Welch KMA, Tidwell CD, Helpern JA. Global cerebral ischemia and intracellular pH during hyperglycemia and hypoglycemia in cats. Stroke. 1988;19:1383-1387.
9. Combs DJ, Dempsey RJ, Maley M, Donaldson D, Smith C. Relationship between plasma glucose, brain lactate, and intracellular pH during cerebral ischemia in gerbils. Stroke. 1990;21:936-942.
10. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. Stroke. 1980;11:347-354.
11. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111-116.
12. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke. 1989;20:84-91.
13. Smith QR, Ziylan YZ, Robinson PJ, Rapopon SI. Kinetics and distribution volumes for tracers of different sizes in the brain plasma space. Brain Res. 1988;462:1-9.
14. Van Uitert RL, Levy DE. Regional brain blood flow in the conscious gerbil. Stroke. 1978;9:67-72.
15. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982;32:1239-1246.
16. de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Determiners of fatal reperfusion brain oedema. Acta Neurochir (Wien). 1990;suppl 51:226-229.
17. Lin B, Busto R, Globus MY-T, Martinez E, Ginsberg MD. Brain temperature modulations during global ischemia fail to influence extracellular lactate levels in rats. Stroke. 1995;26:1634-1638.
18. Kågström E, Smith M-L, Siesjö BK. Recirculation in the rat brain following incomplete ischemia. J Cereb Blood Flow Metab. 1983; 3:183-192.
19. Venables GS, Miller SA, Gibson G, Hardy JA, Strong AJ. The effects of hyperglycaemia on changes during reperfusion following focal cerebral ischemia in the cat. J Neurol Neurosurg Psychiatry. 1985:48:663-669.
20. de Courten-Myers GM, Kleinholz M, Holm P, DeVoe G, Schmitt G, Wagner KR, Myers RE. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 1992;21:120-126.
21. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
22. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M-H, Hennerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
23. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee RJ, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
24. von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
25. Paljärvi L, Rehncrona S, Söderfeldt B, Olsson Y, Kalimo H. Brain lactic acidosis and ischemic cell damage: quantitative ultrastructural changes in capillaries of rat cerebral cortex. Acta Neuropathol (Berl). 1983;60:232-240.
26. Garcia JH, Liu K-F, Yoshida Y, Chen S, Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol. 1994;145:728-740.
27. Aynsley-Green A, Biebuyck JF, Alberti KGMM. Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia. 1973;9:274-281.